Trial of potential Ebola antiviral under way: WHO

The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.

Immunotherapy shows long-term promise in aggressive lymphoma

A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...

page 6 from 40